Langerhans cell histiocytosis is a rare clonal disease characterized by the proliferation of
CD1a-positive immature dendritic cells. The purpose of this article was to present an …

The purpose of this review is to provide an updated overview of the pathogenesis and
treatment of Langerhans cell histiocytosis (LCH). The pathogenesis of LCH remains obscure …

Objective To evaluate the prognostic impact of gastrointestinal involvement (GI-LCH) on the
survival of children with Langerhans cell histiocytosis registered on the international clinical …

Histiocytosis describes a group of diseases that have long been considered enigmatic in the
history of medicine. Recently, novel genomic analyses have identified somatic oncogenic …

Gastrointestinal (GI) tract involvement by Langerhans cell histiocytosis (LCH) is rare and its
clinicopathologic characteristics have only been described in case reports and small series …

Background Langerhans cell histiocytosis (LCH) is a heterogeneous disease with diverse
clinical manifestations. Abdominal organ involvement is rare. Early diagnosis and active …

Langerhans cell histiocytosis is a rare disease with a variable clinical presentation, and its
prognosis and treatment depend on the extent and severity of disease. Although the …

Langerhans cell histiocytosis (LCH) is a heterogeneous histiocytosis characterized by
proliferation of Langerhans cells. While less common, manifestations of digestive tract …

Background: Langerhans cell histiocytosis is a rare disease characterized by the abnormal
proliferation of Langerhans cells within a single organ or multiple organs. This case report …

Background Langerhans cell histiocytosis (LCH) is frequently known to involve multiple
organ systems. However, gastrointestinal involvement by LCH is rare. Methods We describe …